DRCNet Response to the
Drug Enforcement Administration
DRCNet Response to the
Drug Enforcement Administration
| Drug:: | Methylphenidate |
| Classification:: | Stimulant |
| CSA Schedule: | Schedule II |
| Trade or Other Names: | Ritalin |
| Medical Uses: | Attention deficit disorder; Narcolepsy |
| Physical Dependence: | Possible |
| Psychological Dependence: | High |
| Tolerance: | Yes |
| Duration (hours): | 2-4 |
| Usual Method: | Oral; Injected |
| Possible Effects: | Increased alertness; Excitation; Euphoria; Increased pulse rate & blood pressure; Insomnia; Loss of appetite |
| Effects of Overdose: | Agitation; Increased body temperature; Hallucinations; Convulsions; Possible death |
| Withdrawal Syndrome: | Apathy; Long periods of sleep; Irritability; Depression; Disorientation |
Travel back to the DRCNet Response to the DEA Home Page
Travel back to the Drug Chart List
Travel back to the Use & Effects List